Literature DB >> 28529909

Molecular heterogeneity of localized prostate cancer: more different than alike.

Jeffrey J Tosoian1, Emmanuel S Antonarakis2.   

Abstract

Entities:  

Year:  2017        PMID: 28529909      PMCID: PMC5438201          DOI: 10.21037/tcr.2017.02.17

Source DB:  PubMed          Journal:  Transl Cancer Res        ISSN: 2218-676X            Impact factor:   1.241


× No keyword cloud information.
  25 in total

1.  Limitations of a contemporary prostate biopsy: the blind march forward.

Authors:  John T Wei
Journal:  Urol Oncol       Date:  2010 Sep-Oct       Impact factor: 3.498

2.  Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins.

Authors:  Johan Lindberg; Daniel Klevebring; Wennuan Liu; Mårten Neiman; Jianfeng Xu; Peter Wiklund; Fredrik Wiklund; Ian G Mills; Lars Egevad; Henrik Grönberg
Journal:  Eur Urol       Date:  2012-03-31       Impact factor: 20.096

3.  Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.

Authors:  Ashley E Ross; Michael H Johnson; Kasra Yousefi; Elai Davicioni; George J Netto; Luigi Marchionni; Helen L Fedor; Stephanie Glavaris; Voleak Choeurng; Christine Buerki; Nicholas Erho; Lucia L Lam; Elizabeth B Humphreys; Sheila Faraj; Stephania M Bezerra; Misop Han; Alan W Partin; Bruce J Trock; Edward M Schaeffer
Journal:  Eur Urol       Date:  2015-06-06       Impact factor: 20.096

Review 4.  Next-generation sequencing technology in prostate cancer diagnosis, prognosis, and personalized treatment.

Authors:  Shalini S Yadav; Jinyi Li; Hugh J Lavery; Kamlesh K Yadav; Ashutosh K Tewari
Journal:  Urol Oncol       Date:  2015-03-16       Impact factor: 3.498

Review 5.  Genomic Predictors of Outcome in Prostate Cancer.

Authors:  Peter J Boström; Anders S Bjartell; James W F Catto; Scott E Eggener; Hans Lilja; Stacy Loeb; Jack Schalken; Thorsten Schlomm; Matthew R Cooperberg
Journal:  Eur Urol       Date:  2015-04-23       Impact factor: 20.096

6.  Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.

Authors:  Matthew R Cooperberg; Elai Davicioni; Anamaria Crisan; Robert B Jenkins; Mercedeh Ghadessi; R Jeffrey Karnes
Journal:  Eur Urol       Date:  2014-07-02       Impact factor: 20.096

7.  Heterogeneity of prostate cancer in radical prostatectomy specimens.

Authors:  M Aihara; T M Wheeler; M Ohori; P T Scardino
Journal:  Urology       Date:  1994-01       Impact factor: 2.649

8.  The genetic classification of prostate cancer: what's on the horizon?

Authors:  Helen Ross-Adams; Alastair D Lamb
Journal:  Future Oncol       Date:  2016-02-09       Impact factor: 3.404

9.  The genomic complexity of primary human prostate cancer.

Authors:  Michael F Berger; Michael S Lawrence; Francesca Demichelis; Yotam Drier; Kristian Cibulskis; Andrey Y Sivachenko; Andrea Sboner; Raquel Esgueva; Dorothee Pflueger; Carrie Sougnez; Robert Onofrio; Scott L Carter; Kyung Park; Lukas Habegger; Lauren Ambrogio; Timothy Fennell; Melissa Parkin; Gordon Saksena; Douglas Voet; Alex H Ramos; Trevor J Pugh; Jane Wilkinson; Sheila Fisher; Wendy Winckler; Scott Mahan; Kristin Ardlie; Jennifer Baldwin; Jonathan W Simons; Naoki Kitabayashi; Theresa Y MacDonald; Philip W Kantoff; Lynda Chin; Stacey B Gabriel; Mark B Gerstein; Todd R Golub; Matthew Meyerson; Ashutosh Tewari; Eric S Lander; Gad Getz; Mark A Rubin; Levi A Garraway
Journal:  Nature       Date:  2011-02-10       Impact factor: 49.962

10.  Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.

Authors:  Colin S Cooper; Rosalind Eeles; David C Wedge; Peter Van Loo; Anne Y Warren; Christopher S Foster; Hayley C Whitaker; Ultan McDermott; Daniel S Brewer; David E Neal; Gunes Gundem; Ludmil B Alexandrov; Barbara Kremeyer; Adam Butler; Andrew G Lynch; Niedzica Camacho; Charlie E Massie; Jonathan Kay; Hayley J Luxton; Sandra Edwards; ZSofia Kote-Jarai; Nening Dennis; Sue Merson; Daniel Leongamornlert; Jorge Zamora; Cathy Corbishley; Sarah Thomas; Serena Nik-Zainal; Sarah O'Meara; Lucy Matthews; Jeremy Clark; Rachel Hurst; Richard Mithen; Robert G Bristow; Paul C Boutros; Michael Fraser; Susanna Cooke; Keiran Raine; David Jones; Andrew Menzies; Lucy Stebbings; Jon Hinton; Jon Teague; Stuart McLaren; Laura Mudie; Claire Hardy; Elizabeth Anderson; Olivia Joseph; Victoria Goody; Ben Robinson; Mark Maddison; Stephen Gamble; Christopher Greenman; Dan Berney; Steven Hazell; Naomi Livni; Cyril Fisher; Christopher Ogden; Pardeep Kumar; Alan Thompson; Christopher Woodhouse; David Nicol; Erik Mayer; Tim Dudderidge; Nimish C Shah; Vincent Gnanapragasam; Thierry Voet; Peter Campbell; Andrew Futreal; Douglas Easton; Michael R Stratton
Journal:  Nat Genet       Date:  2015-03-02       Impact factor: 38.330

View more
  6 in total

Review 1.  Molecular correlates of intermediate- and high-risk localized prostate cancer.

Authors:  Huihui Ye; Adam G Sowalsky
Journal:  Urol Oncol       Date:  2018-03-02       Impact factor: 3.498

2.  Electroporation-based proteome sampling ex vivo enables the detection of brain melanoma protein signatures in a location proximate to visible tumor margins.

Authors:  Ilai Genish; Batel Gabay; Angela Ruban; Yona Goldshmit; Amrita Singh; Julia Wise; Klimentiy Levkov; Avshalom Shalom; Edward Vitkin; Zohar Yakhini; Alexander Golberg
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.752

3.  A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.

Authors:  Constantin Georgescu; Joshua M Corbin; Sandra Thibivilliers; Zachary D Webb; Yan D Zhao; Jan Koster; Kar-Ming Fung; Adam S Asch; Jonathan D Wren; Maria J Ruiz-Echevarría
Journal:  BMC Cancer       Date:  2019-05-06       Impact factor: 4.430

4.  The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype.

Authors:  Patrick B Thomas; Penny Jeffery; Manuel D Gahete; Eliza Whiteside; Carina Walpole; Michelle Maugham; Lidija Jovanovic; Jennifer Gunter; Elizabeth Williams; Colleen Nelson; Adrian Herington; Raul M Luque; Rakesh Veedu; Lisa K Chopin; Inge Seim
Journal:  PeerJ       Date:  2021-02-01       Impact factor: 2.984

Review 5.  Focal therapy for prostate cancer: what is really needed to move from investigational to valid therapeutic alternative?-a narrative review.

Authors:  Antony Pellegrino; Giuseppe O Cirulli; Elio Mazzone; Francesco Barletta; Simone Scuderi; Mario de Angelis; Giuseppe Rosiello; Giorgio Gandaglia; Francesco Montorsi; Alberto Briganti; Armando Stabile
Journal:  Ann Transl Med       Date:  2022-07

6.  Nondestructive protein sampling with electroporation facilitates profiling of spatial differential protein expression in breast tumors in vivo.

Authors:  Edward Vitkin; Amrita Singh; Zohar Yakhini; Alexander Golberg; Julia Wise; Shay Ben-Elazar
Journal:  Sci Rep       Date:  2022-09-23       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.